Dermata Therapeutics Files Q1 2025 10-Q Report
Ticker: DRMAW · Form: 10-Q · Filed: May 14, 2025 · CIK: 1853816
| Field | Detail |
|---|---|
| Company | Dermata Therapeutics, Inc. (DRMAW) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financial-report
Related Tickers: DRMA
TL;DR
Dermata Therapeutics filed its Q1 2025 10-Q. Check financials.
AI Summary
Dermata Therapeutics, Inc. filed its quarterly report for the period ending March 31, 2025. The company, located at 3525 Del Mar Heights Rd., #322, San Diego, CA 92130, is involved in the Pharmaceutical Preparations industry. This filing provides an update on its financial status and business operations for the first quarter of 2025.
Why It Matters
This filing provides investors with the latest financial and operational details for Dermata Therapeutics, Inc., crucial for understanding the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Dermata Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 20250331 — Reporting Period End Date (The end date for the financial information presented in the 10-Q.)
- 20250514 — Filing Date (The date the 10-Q report was officially filed with the SEC.)
Key Players & Entities
- Dermata Therapeutics, Inc. (company) — Filer of the 10-Q report
- 3525 Del Mar Heights Rd., #322, San Diego, CA 92130 (location) — Company's business and mailing address
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
- 001-40739 (company_id) — SEC File Number
FAQ
What is the primary business of Dermata Therapeutics, Inc.?
Dermata Therapeutics, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code 2834.
What is the fiscal year end for Dermata Therapeutics, Inc.?
The fiscal year end for Dermata Therapeutics, Inc. is December 31 (1231).
What is the SEC file number for Dermata Therapeutics, Inc.?
The SEC file number for Dermata Therapeutics, Inc. is 001-40739.
What is the business address of Dermata Therapeutics, Inc.?
The business address of Dermata Therapeutics, Inc. is 3525 Del Mar Heights Rd., #322, San Diego, CA 92130.
For what period is this 10-Q filing?
This 10-Q filing is for the period ending March 31, 2025 (20250331).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Dermata Therapeutics, Inc. (DRMAW).